Who owns CHEMOMAB THERAPEUTICS LTD SPONSORED ADS?
- Ticker: CMMB
- CUSIP Number: 16385c203
Tip: Access positions for across all investors
Analyze quarterly positions in Chemomab Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Chemomab Therapeutics stock
Who bought or sold CHEMOMAB THERAPEUTICS LTD SPONSORED ADS this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| ADAR1 Capital Management | 80k | $126k | 0% | Mar 2026 |
|
| Citadel Advisors | 64k | $101k | -38% | Mar 2026 |
|
| Kestra Private Wealth Services | 62k | $97k | 19% | Mar 2026 |
|
| Ikarian Capital | 52k | $81k | 0% | Mar 2026 |
|
| XTX Topco | 19k | $31k | 100% | Dec 2025 |
|
| Rhumbline Advisers | 18k | $29k | 3% | Mar 2026 |
|
| SmartHarvest Portfolios | 15k | $23k | 100% | Mar 2026 |
|
| Virtu Financial | 11k | $18k | 100% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 8.4k | $13k | 4% | Mar 2026 |
|
| Philadelphia Investment Partners | 8.2k | $13k | 100% | Mar 2026 |
|
| GAMMA Investing | 7.6k | $12k | 201% | Mar 2026 |
|
| Morgan Stanley | 4.6k | $7.2k | 21% | Mar 2026 |
|
| SBI Securities | 28.00 | $43.999200 | 8% | Mar 2026 |
|
| UBS Group | 8.00 | $13.000000 | -100% | Mar 2026 |
|
| Caitong International Asset Management | 8.00 | $13.000000 | 100% | Mar 2026 |
|
Who sold out of Chemomab Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Stonepine Capital Management | Sep 2025 | 30k | $79k |
| Jane Street | Dec 2025 | 16k | $26k |